Page last updated: 2024-12-11

beta-apo-13-carotenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-apo-13-carotenone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

13-apo-beta-carotenone : An apo carotenoid compound arising from oxidative degradation of the beta,beta-carotene skeleton at the 13-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5363697
CHEBI ID53175
SCHEMBL ID5699211
SCHEMBL ID4109774
MeSH IDM0193778

Synonyms (23)

Synonym
beta-apo-13-carotenone
13-apo-beta-carotenone
13-apo-beta-caroten-12-one
CHEBI:53175
(3e,5e,7e)-6-methyl-8-(2,6,6-trimethylcyclohexen-1-yl)octa-3,5,7-trien-2-one
C20696
SCHEMBL5699211
SCHEMBL4109774
(3e,5e,7e)-6-methyl-8-(2,6,6-trimethyl-1-cyclohexenyl)-3,5,7-octatrien-2-one
UBTNVRPIHJRBCI-LUXGDSJYSA-N
(3e,5e,7e)-6-methyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3,5,7-octatrien-2-one #
17974-57-1
HY-101953
CS-6999
Q27124001
(beta)-apo-13-carotenone
b-apo-13-carotenone
d'orenone
(3e,5e,7e)-6-methyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)octa-3,5,7-trien-2-one
MS-23646
QTB ,
??-apo-13-carotenone
AKOS040740633

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Other apocarotenoids are either poorly absorbed or rapidly metabolized or cleared, and so are absent or limited in blood."( Limited appearance of apocarotenoids is observed in plasma after consumption of tomato juices: a randomized human clinical trial.
Cichon, MJ; Cooperstone, JL; Curley, RW; Francis, DM; Harrison, EH; Novotny, JA; Riedl, KM; Schwartz, SJ, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
apo carotenoidA compound arising from loss of part of the carotene skeleton (excluding retinoids)
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
carotenoid cleavage620
carotenoid cleavage422

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's0 (0.00)29.6817
2010's10 (90.91)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]